2 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
Follow Germ Cell Tumors: new trials by email Literature Review of Germ Cell Tumors trials Research Report on Germ Cell Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells, Fludarabine phosphate - B-Cell Lymphoma, Myelodysplastic Syndromes (MDS) | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 80 | 2022-11-01 | 2026-08-07 |
| Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies AeroEclipse II Breath Actuated Nebulizer, Bintrafusp alfa, Azacytidine - Sarcomas, Melanomas | Phase 1 / Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2021-12-14 | 2021-12-17 | |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Magnetic resonance high intensity focused ultrasound, Lyso-thermosensitive liposomal doxorubicin - Pediatric Cancer, Solid Tumors | Phase 1 | Terminated | AeRang Kim | 2 | 2016-10-01 | 2023-08-29 |
| Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Simvastatin, Cyclophosphamide, Topotecan - Retinoblastoma, Clear Cell Sarcoma | Phase 1 | Completed | Emory University | 13 | 2015-02-01 | 2020-04-03 |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy Recombinant Human Thrombopoietin - Germ Cell Tumors, Hepatic Cancer | Phase 1 / Phase 2 | Completed | St. Jude Children's Research Hospital | 40 | 2000-06-01 | 2008-04-10 |
Neoplasms, Germ Cell and Embryonal (5) · Neuroblastoma (3) · Osteosarcoma (3) · Rhabdomyosarcoma (3) · Sarcoma (3) · Carcinoma, Renal Cell (2) · Sarcoma, Ewing (2) · Wilms Tumor (2) · Carcinoma, Hepatocellular (1) · Hepatoblastoma (1) · Hodgkin Disease (1) · Jacobs syndrome (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Plasma Cell (1)
Neoplasms by Histologic Type (5) · Neoplasms (4) · Neoplasms by Site (4) · Neoplasms, Connective and Soft Tissue (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Nerve Tissue (4) · Neuroectodermal Tumors (4) · Adenocarcinoma (3) · Carcinoma (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Kidney Neoplasms (3) · Male Urogenital Diseases (3) · Myosarcoma (3)
Cyclophosphamide (2) · Azacitidine (1) · Granulocyte Colony-Stimulating Factor (1) · Simvastatin (1) · Thrombopoietin (1) · Topotecan (1) · bintrafusp alfa protein, human (1) · fludarabine (1) · fludarabine phosphate (1) · pegylated granulocyte colony-stimulating factor (1)
AeRang Kim (1) · Emory University (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · St. Jude Children's Research Hospital (1)
United States (5)
AeRang Kim, MD, PhD (1) · David Marin, MD (1) · David S Schrump, M.D. (1) · Kelly Goldsmith, MD (1) · Najat C. Daw, M.D. (1)